Therefore, using two complementary MJD mouse models, we observed that CR and SIRT1 overexpression ameliorate the neuropathology in two stages of the disease: postsymptomatic and at an initial stage. This evidence concerns the gene SIRT1 and Spinocerebellar ataxia type 3.